جست‌وجوی استاد و پژوهشگر

Nigel Leeمشاهده پروفایل

مدرس

• Midwifery
• Labour Pain Management
• Sterile Water Injections
• +۷ مورد دیگر

Dr. Nigel Lee is a Lecturer and NHMRC Emerging Leadership Fellow at the University of Queensland's School of Nursing, Midwifery and Social Work. He also serves as an Adjunct Associate Professor with the Molly Wardaguga Research Centre at Charles Darwin University and is affiliated with the Centre for Innovation in Pain and Health Research (CIPHeR). Dr. Lee completed his PhD in 2013 at Australian Catholic University, researching sterile water injections for managing back pain in labour. His research interests span midwifery care, labour pain management, breastfeeding support, perineal trauma prevention, and consent practices during childbirth. He has developed significant expertise in randomized controlled trials and mixed methods research design, with a strong focus on translating research into clinical practice. His recent publications (2023-2025) demonstrate continued productivity across multiple areas of maternal health, with particular emphasis on labour induction trends, breastfeeding education, perineal trauma prevention, and consent practices during labour and birth. These works reflect his commitment to improving evidence-based midwifery practice through rigorous research. Scientific Awards: NHMRC Emerging Leadership Fellow NHMRC Investigator Grant (2023-2027) for 'Water injections: Transforming childbirth pain management for any woman, anywhere' Dr. Lee actively supervises multiple PhD and Master's students across various topics including respectful maternity care, perineal trauma prevention, and breastfeeding support. His current NHMRC-funded projects extend through 2027, demonstrating sustained research productivity. He collaborates extensively with researchers across Australia, Sweden, the UK, and the USA, reflecting his strong international research network. Dr. Lee's work bridges clinical practice and research, with a clear focus on improving maternal health outcomes through evidence-based practice. His leadership in the Consortium for Sterile Water Injections Research and Training (ConSIRT) demonstrates his commitment to translating research findings into practical clinical applications.

• Biology
• Cell Biology
• Molecular Biology
• +۷ مورد دیگر

Paolo Macchi is a Full Professor at the University of Trento, holding roles in the Department of Cellular, Computational and Integrative Biology (CIBIO) and the Centre for Medical Sciences (CISMED). He serves as Director of CIBIO and Rector's delegate for Disability Support, and is a member of the University Council. His expertise spans cell biology, molecular biology, neurobiology, and RNA biology, with a focus on RNA localization, translation regulation, and systems biology approaches. He teaches Biologia generale e molecolare , covering cellular structures, molecular mechanisms, and genomic processes. Research highlights include studies on RNA-binding proteins (e.g., RALY, HuD) and their roles in neuronal function, as well as interdisciplinary work on bio-hybrid systems (e.g., TiO2 films, memristive devices) interfacing neurons with materials. His work integrates molecular biology, genomics, and engineering to explore neural mechanisms, cancer biology, and developmental processes. Publications span RNA regulation in telomere dynamics, neuronal excitability, and artificial cell systems. He has developed cell-free systems and functionalized biomaterials for biomedical applications. Collaborative projects include memristive devices for neuromorphic modeling and lipidomics analysis under stress conditions.

Federico Germaniمشاهده پروفایل

پژوهشگر ارشد

• Disinformation
• Misinformation
• Infodemic Management
• +۱۲ مورد دیگر

Federico Germani, a postdoctoral researcher at the Institute of Biomedical Ethics and History of Medicine (IBME) within the Faculty of Medicine at the University of Zurich, holds a PhD in Molecular Life Sciences and additional qualifications in International Relations. He founded Culturico, a non-profit cultural platform combating misinformation, and serves as a rapporteur for the World Health Organization (WHO) on infodemic ethics. His work bridges biomedical research, digital society, and public health ethics. Bachelor's in Biology, University of Milan (2013) Master's in Cellular and Molecular Biology, University of Milan (2015) PhD in Molecular Life Sciences, University of Zurich (2019) Graduate Diploma in International Relations, University of London (2018) Federico's research focuses on digital misinformation, pandemic preparedness, and ethical frameworks for AI in health communication. His expertise spans infodemic management, information literacy, and the intersection of technology and ethics. His recent work explores AI-driven disinformation mechanisms, systematic evaluation biases in language models, and critical thinking interventions. His 15 most recent publications (2025-2024) address AI ethics, pandemic communication, and misinformation analysis. Articles include topics such as algorithmic accountability, emotional bias in AI, and preference epidemiology for patient-centered healthcare.

Melanie R. McReynoldsمشاهده پروفایل

استادیار

• Aging
• Metabolism
• NAD+ Homeostasis
• +۸ مورد دیگر

Dr. Melanie R. McReynolds serves as Assistant Professor of Biochemistry and Molecular Biology at Pennsylvania State University, holding the Dorothy Foehr Huck and J. Lloyd Huck Early Career Chair. She maintains dual affiliations with the Department of Biochemistry and Molecular Biology and the Molecular, Cellular, and Integrative Biosciences Program. Her academic foundation includes: B.S. in Chemistry and Physics from Alcorn State University M.S. in Biological Sciences via Penn State's NIH-funded Bridges to the Doctorate Program Ph.D. in Biochemistry, Microbiology and Molecular Biology from Penn State University Dr. McReynolds' research centers on metabolic decline during aging, with emphasis on NAD+ homeostasis and stress response mechanisms. Her laboratory employs high-resolution liquid-chromatography mass spectrometry coupled with in vivo isotope tracing to investigate how metabolism adapts to acute and chronic stress in age-related disease models. This work aims to identify targetable molecular pathways for restoring youthful metabolism through therapeutics and nutraceuticals. Analysis of her 14 most recent publications (2014-2021) reveals three dominant research trajectories: NAD+ flux dynamics in aging models, CD38-mediated NAD+ depletion during senescence, and metabolic adaptations in stress-induced aging. Her work spans model organisms from C. elegans to mammals, with increasing focus on translational applications in cancer and neurodegenerative disorders since 2020. Her scientific contributions have been recognized through: HHMI Hanna H. Gray Fellows Program (2018) Burroughs Wellcome Fund Postdoctoral Research Enrichment Program (2018) Inaugural Intersections Science Fellowship (2021) University of Utah Rising Stars in Metabolism (2021) Dr. McReynolds actively mentors trainees across career stages while securing research funding through her HHMI Hanna H. Gray award and pursuing additional external grants. Her lab operates with structured goals to answer fundamental questions about metabolic aging, attract sustained funding, and provide comprehensive training opportunities that emphasize diversity in science. The McReynolds Laboratory in Huck Life Sciences Building maintains three core research thrusts: NAD+ Homeostasis, Whole-Body Mass Balance, and Stress-Induced Aging and Disease. The lab culture prioritizes showcasing excellence through diverse scientific perspectives while developing therapeutic strategies for age-related metabolic disorders.

Jan Liphardtمشاهده پروفایل

دانشیار

• Biophysics
• Bioengineering
• Single-Molecule Studies
• +۵ مورد دیگر

Jan Liphardt is an Associate Professor of Bioengineering at Stanford University , leading the Liphardt Lab. His work bridges physics, engineering, and biology , focusing on single-molecule dynamics, non-equilibrium statistical mechanics, and privacy-preserving medical AI . He is affiliated with the Shriram Center and has pioneered tools like Secure Multiparty Computation for global health data analysis. Education : BA from Reed College (1996), PhD from Cambridge University (1999). His research spans single-molecule biophysics (e.g., RNA dynamics, nuclear pore mechanics) and applied projects in digital health , including a privacy-preserving COVID-19 symptom tracker with 3.6 million reports. Recent articles emphasize mechanogenetics , chromatin dynamics , and wearable stress sensors . Scientific awards include the Searle Scholar Sloan Research Fellowship Hellman Fellowship Mohr Davidow Innovator’s Award (2007) His lab mentors PhD students and postdocs in interdisciplinary methods, and he teaches courses on synthetic biology , AI in bioengineering , and blockchain applications . Collaborations with Lawrence Berkeley National Lab and UC Berkeley highlight his academic journey.

• Alzheimer's Disease
• Dementia
• Geriatric Psychiatry
• +۳ مورد دیگر

Dr. David J. Loreck is a Clinical Assistant Professor at the University of Maryland School of Medicine's Department of Psychiatry. He leads the Baltimore VAMC Mental Health Consultation Service and Neuropsychiatry Clinic, specializing in Alzheimer's Disease, Dementia, and Geriatric Psychiatry. He holds board certifications in Adult Psychiatry, Geriatric Psychiatry, and Neuropsychiatry. Education: BA in Political Science and English Literature from University of Maryland College Park (1979), M.D. from University of Texas Medical School (1987 with honors/AOA), and completed residency/fellowship training at University of Maryland Medical System and Johns Hopkins School of Medicine (Alzheimer's Disease Research Center). Research focuses on dementia/delirium treatment in the elderly, with participation in VA clinical trials. Major contributions include developing the Baltimore VAMC Alzheimer's Disease/Memory Disorders Clinic and serving on VA Dementia Clinical Care and Delirium Field Advisory committees. He also chairs regional dementia care initiatives and advises Maryland Alzheimer's Disease boards. Awards: Graduated with Honors and Alpha Omega Alpha membership from UT Medical School. Key professional roles include service on national VA committees, Maryland Alzheimer's Scientific Board, and VA clinical care oversight. Advocacy and grants: His work integrates clinical practice with policy improvements for elderly patients with neurocognitive disorders. He has authored/co-authored over 14 peer-reviewed articles on dementia assessment, neuropsychiatric symptoms, and elder care innovation.

Changrui Xiaoمشاهده پروفایل

استادیار

• Genomics
• Neurology
• Rare Diseases
• +۳ مورد دیگر

Changrui Xiao, MD, serves as an Assistant Professor in the Department of Neurology at the University of California, Irvine (UCI) School of Medicine, where he specializes in genomic approaches to diagnosing rare neurological disorders through clinical and research initiatives. His research spans genomics, neurology, and rare diseases with emphasis on neurodevelopmental disorders and clinical genomic testing. Key interests include novel gene discovery, variant interpretation frameworks, and leveraging advanced sequencing technologies to improve diagnostic yield for Mendelian conditions. His work addresses critical gaps in reporting variants in candidate genes and translating genomic findings into clinical practice. Recent publications (2024-2025) demonstrate consistent focus on genomic diagnostics for undiagnosed rare diseases, featuring telehealth evaluation methods, repeat expansion disorder discovery, and non-coding variant analysis. His research frequently involves large-scale consortia data and emphasizes practical implementation of genomic technologies in clinical settings. Dr. Xiao contributes to major NIH-funded initiatives including the Genomics Research to Elucidate the Genetics of Rare Diseases (GREGoR) Consortium and the Undiagnosed Diseases Network. His work is supported by multiple NHGRI grants (U01 HG011745, U24 HG011746, U01 HG011762) focusing on genomic infrastructure development and diagnostic pathway optimization. He actively participates in collaborative efforts integrating clinical expertise with genomic research through platforms like Matchmaker Exchange and ClinVar, emphasizing systematic data sharing to accelerate gene validation and improve diagnostic outcomes for rare disease patients.

Beatriz Matosمشاهده پروفایل

پژوهشگر

• Toxicology
• Immunology
• Biochemical Responses
• +۲ مورد دیگر

Beatriz Matos serves as a Non-PhD Researcher at the Department of Environmental Engineering within the Faculty of Science and Technology at Universidade Nova de Lisboa. Holding an MSc in Biochemistry (2019), she contributes to the PAHMIX project focused on molecular approaches to environmental carcinogen risk assessment through her expertise in toxicology and nanomaterial impacts. Her educational background includes: Master in Biochemistry (2019, Universidade Nova de Lisboa) Specializing in Environmental Toxicology , Matos investigates nano-pollutant and chemical mixture effects using Zebrafish , Daphnia magna , and hepatocyte models . Her work bridges nanotoxicology , immunological responses , and biochemical mechanisms , with significant contributions to understanding PAH mixtures and quantum dot toxicity. This research directly informs advanced environmental risk frameworks through molecular-level insights into pollutant impacts. Analysis of her 2019-2025 publications reveals dual research trajectories: rigorous experimental toxicology focusing on aquatic systems and pollutant mechanisms, alongside critical scholarship on indigenous health policy in Brazil. This interdisciplinary approach connects laboratory findings with socio-environmental contexts, particularly regarding isolated indigenous communities facing environmental and health threats. Currently embedded in the PAHMIX project, Matos contributes experimental design and molecular analysis to environmental carcinogen research. While no formal student advisement is documented, her collaborative work engages with interdisciplinary teams across toxicology and policy domains. She operates within FCT/UNL's Environment and Sustainability Center (CENSE), collaborating with the Portuguese Marine Litter Association and Ecozoic Junior Company. Her laboratory work integrates primary cell culture techniques and biomarker analysis within the department's environmental engineering research infrastructure, emphasizing practical applications for ecological risk assessment.

• Hematopoiesis
• Erythropoiesis
• Leukemia
• +۴ مورد دیگر

Min Jung Kim, PhD is an Assistant Professor in the Department of Pediatrics at the University of Maryland School of Medicine , with expertise in molecular and cellular biology. Her research focuses on microRNA regulation in hematopoiesis and leukemia, particularly erythropoiesis and RAB14's role as a novel inhibitor. Education: B.S. & M.S. in Genetic Engineering (Cheongiu University, Korea), Ph.D. in Molecular & Cell Biology (University of Texas at Dallas), Postdoctoral Training at Johns Hopkins University and University of Maryland School of Medicine. Dr. Kim's research explores: MicroRNA functions in erythroid development RAB14's molecular mechanisms in erythropoiesis Erythroid-specific gene regulation Therapeutic targets for leukemia Cell signaling pathways in hematopoietic stem cells Animal models (mice, frogs) for hematopoietic studies Her recent articles highlight trends in: MicroRNA interactions in hematological disorders Microfluidic-based cell processing Cytokine impacts on erythroid cells Gene editing and functional genomics Non-coding RNA in leukemia Developmental gene regulation across species Dr. Kim collaborates with the Civin Lab and contributes to understanding erythropoiesis through advanced molecular techniques and translational research.

Simona Corsoمشاهده پروفایل

دانشیار

• Molecular Oncology
• Cancer Resistance Mechanisms
• Patient-Derived Xenografts (PDX)
• +۳ مورد دیگر

Simona Corso is an Associate Professor at the Department of Oncology, University of Turin, and Principal Investigator at the Cancer Molecular Biology Lab within the Candiolo Cancer Institute, FPO-IRCCS. Her research focuses on mechanisms of cancer resistance and the development of molecularly annotated patient-derived xenograft (PDX) models for gastro-esophageal cancers. She coordinates interdisciplinary studies on cell-autonomous and non-cell-autonomous resistance pathways, contributing to translational oncology and precision medicine. Corso’s work includes generating one of the largest academic PDX platforms for gastro-esophageal tumors, enabling preclinical therapeutic screening and biomarker discovery. Collaborations, such as with Prof. Silvia Giordano, highlight her role in advancing preclinical models and understanding tumor heterogeneity. Her teaching responsibilities include courses on Cancer Cellular Biology, Histology, and Molecular Medicine within undergraduate and graduate programs at the University of Turin. She actively participates in academic governance through roles in the Department Council and Research Commission.